Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06855654

Recruiting

Promoting Resilience in Women With Breast Cancer (PRISM -MBC) (PRISM-MBC)

Breast Cancer | Metastatic Breast Cancer
NCT06795529

Recruiting

Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer (TARGET-PC)

Metastatic Breast Cancer
NCT06784921

Recruiting

To Investigate the Real-world Efficacy and Safety of Sacituzumab Govitecan for HER2 Negative Metastatic Breast Cancer Patients in China. (SACIT-OUT)

Breast Cancer Metastatic
NCT06750484

Recruiting

Trial of Trastuzumab Deruxtecan in Previously Treated HER2

Breast Cancer Metastatic
NCT06746688

Recruiting

A First-in-human, Clinical Trial Assessing the Safety of ES2B-C001-S01 With or Without [Adjuvant] in Patients With HER2-expressing Metastatic Breast Cancer.

Breast Cancer | Breast Cancer Metastatic
NCT06635096

Not yet recruiting

The Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast Cancer

Breast Cancer Female
NCT06633276

Recruiting

Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)

Breast Cancer Invasive
NCT06596018

Recruiting

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

Breast Adenocarcinoma
NCT06507618

Recruiting

Pre-Operative Window of ET to Inform RT Decisions (POWER II) (POWER II)

Breast Cancer Female
NCT06500494

Recruiting

To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment (VINOREAL)

Advanced Breast Cancer
NCT06474975

Not yet recruiting

Intra-SURGerY High-resolution Specimen PET/CT Imager for Margin Assessment in Early-stage Breast Cancer (SURGYPET)

Breast Cancer | Breast-conserving Surgery
NCT06433609

Not yet recruiting

Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer

Advanced Breast Cancer
NCT06341894

Recruiting

Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer

Early Breast Cancer
NCT06322888

Recruiting

Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

Breast Cancer | Breast Cancer Female
NCT06308939

Not yet recruiting

Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial

Metastatic Breast Cancer
NCT06268652

Recruiting

Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer

Breast Cancer | Refractory Breast Carcinoma
NCT06243432

Recruiting

Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast Cancer (CYCLHER)

Advanced Breast Carcinoma
NCT06096545

Recruiting

Axillary Management After Neoadjuvant Chemotherapy

Breast Cancer | Breast Neoplasms | Breast Cancer Female
NCT05949541

Recruiting

Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer (BCTOP-L-M01)

Breast Cancer | Advanced Breast Cancer
NCT05893368

Recruiting

New Model for Integrating Person-based Care (PbC) in the Treatment of Advanced HER2-negative Breast Cancer (PERGIQUAL)

Advanced Breast Cancer
NCT05848141

Recruiting

Rowing Following Breast Cancer Chemotherapy

Breast Cancer Survivors
NCT05838001

Recruiting

Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable Breast Cancer After Neoadjuvant Therapy

Breast Cancer | Breast-conserving Surgery
NCT05809128

Recruiting

Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging

Breast Cancer Patients
NCT05755581

Not yet recruiting

Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients

Female Breast Cancer
NCT05642897

Recruiting

Mind Programme for Women With Breast Cancer (MIND)

Breast Cancer Female
NCT05629429

Recruiting

Olaparib Maintenance Therapy in Metastatic Breast Cancer

Metastatic Breast Cancer
NCT05586256

Recruiting

Ultra-hypofractionated Radiotherapy in Breast Cancer Patients

Female Breast Cancer
NCT05445050

Recruiting

mULM to Support Breast Cancer Diagnosis and Therapy

Primary Breast Cancer
NCT05420779

Recruiting

A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations

Breast Cancer Metastatic
NCT05401942

Not yet recruiting

Real-time Tele-monitoring Versus Routine Monitoring of Breast Cancer Patients Receiving Adjuvant Systemic Therapy

Breast Cancer Female
NCT05386628

Recruiting

The Effect of Myofascial Chain Release Techniques on Shoulder Joint Range of Motion in Breast Cancer Survivors

Breast Cancer Survivors
NCT05337657

Recruiting

A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer

Advanced Breast Cancer
NCT05331326

Recruiting

A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM Pathway

Metastatic Breast Cancer
NCT05314114

Recruiting

Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT

Breast Cancer Female
NCT05305963

Recruiting

Breast CANcer Risk Assessment in Younger Women: BCAN-RAY (BCAN-RAY)

Breast Cancer Female
NCT05274893

Not yet recruiting

A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer

Advanced Breast Cancer
NCT05255523

Not yet recruiting

Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer

Advanced Breast Cancer
NCT05186545

Recruiting

An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer

Breast Cancer | Breast Cancer Female
NCT05020964

Not yet recruiting

Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib

Advanced Breast Cancer
NCT05016349

Not yet recruiting

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Breast Cancer Female
NCT04990921

Recruiting

Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer

Metastatic Breast Cancer
NCT04680715

Recruiting

Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer (RPOS+2)

Localized Breast Cancer
NCT04659499

Not yet recruiting

Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer

Early Breast Cancer
NCT04616729

Recruiting

DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation (Depo-Trigger)

Breast Cancer Female
NCT04480619

Not yet recruiting

Safety and Efficacy of Ga68-IAC PET/CT for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients (Shiva)

Angiogenic Breast Cancer
NCT04304352

Recruiting

Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients (VEX)

Advanced Breast Cancer
NCT04269967

Recruiting

A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors

Breast Cancer Female
NCT04258735

Recruiting

Genetic Characteristics of Metastatic Breast Cancer Patients

Metastatic Breast Cancer
NCT04246502

Not yet recruiting

Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of HER2-positive Metastatic Breast Cancer

Metastatic Breast Cancer
NCT04145986

Recruiting

Evaluation of Prognostic Monitoring for Young Breast Cancer Patients

Breast Cancer Female

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations